ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Raman Bhaumik and Thesis Pharmacy Welcome Meagan Kurtz, PharmD, as Vice President of Clinical Services

Industry Leader Meagan Kurtz Brings Over a Decade of Compounding Expertise to Advance Clinical Innovation at Thesis Pharmacy.

(PRUnderground) November 4th, 2025

Thesis Pharmacy, owned by Dr. Jay Bhaumik and co-owned by Chief People Officer Raman Bhaumik, proudly announces the appointment of Meagan Kurtz, PharmD, as the company’s new Vice President of Clinical Services. With more than 12 years of expertise in pharmacy compounding and a commitment to advancing patient care, Meagan brings a wealth of clinical and operational knowledge to the organization.

In her new role, Meagan will oversee the development and implementation of clinical strategies that enhance safety, efficiency, and innovation across Thesis Pharmacy’s operations. Her leadership will strengthen the company’s focus on sterile formulations, aseptic operations, and patient and provider education.

Meagan represents exactly what Thesis Pharmacy stands for – expertise built on compassion and innovation rooted in integrity,” said Raman Bhaumik, Chief People Officer and Co-Owner of Thesis Pharmacy. “At Thesis Pharmacy, our people are our purpose, and Meagan embodies that vision. Her knowledge and leadership will help us continue redefining how personalized medicine is delivered.”

Meagan earned her Doctor of Pharmacy (PharmD) from the University of Arkansas for Medical Sciences and a Bachelor of Science in Biochemistry from Lyon College. Licensed to practice pharmacy in multiple states, she is deeply committed to bridging science and compassion in clinical practice.

This appointment reflects Thesis Pharmacy’s continued investment in top-tier clinical leadership and its commitment to innovation in patient care.

About Thesis Pharmacy

Thesis Pharmacy is a leading provider of compounded medications, dedicated to delivering high-quality, personalized pharmaceutical care. Led by co-owner and Chairman, Dr. Jay Bhaumik, and co-owner and Chief People Officer Raman Bhaumik, also a licensed pharmacist with a passion for operational innovation and advancing the next generation of healthcare professionals, the company combines advanced compounding techniques, clinical expertise, and compassionate service to meet the unique needs of patients and healthcare providers across the nation.

For more information about Thesis Pharmacy, visit https://thesispharmacy.com/.

The post Raman Bhaumik and Thesis Pharmacy Welcome Meagan Kurtz, PharmD, as Vice President of Clinical Services first appeared on

Press Contact

Name: Autumn Arnold
Phone: 469-871-0172
Email: Contact Us

Original Press Release.

Recent Quotes

View More
Symbol Price Change (%)
AMZN  233.22
+0.00 (0.00%)
AAPL  278.85
+0.00 (0.00%)
AMD  217.53
+0.00 (0.00%)
BAC  53.65
+0.00 (0.00%)
GOOG  320.12
+0.00 (0.00%)
META  647.95
+0.00 (0.00%)
MSFT  492.01
+0.00 (0.00%)
NVDA  177.00
+0.00 (0.00%)
ORCL  201.95
+0.00 (0.00%)
TSLA  430.17
+0.00 (0.00%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.